awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38036326-5DDFECC2-727E-489F-8E1A-CDC33FDD3EDB
Q38036326-5DDFECC2-727E-489F-8E1A-CDC33FDD3EDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38036326-5DDFECC2-727E-489F-8E1A-CDC33FDD3EDB
Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia.
P2860
Q38036326-5DDFECC2-727E-489F-8E1A-CDC33FDD3EDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38036326-5DDFECC2-727E-489F-8E1A-CDC33FDD3EDB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ec69138b4e5fda45537e81cf71a6c3a0188a33f1
P2860
Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.